PEGylated Factor IX (PolyTherics/Pro Bono Bio/Cantab)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NamePEGylated Factor IX (PolyTherics/Pro Bono Bio/Cantab)
Drug Alias NameFactor IX biobsuperior (PolyTherics/Pro Bono Bio/Cantab Biopharmaceuticals)Factor IX biobetter (PolyTherics/Pro Bono Bio/Cantab Biopharmaceuticals)TheraPEG Factor IX
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCoagulation factor IX stimulants
TargetsCoagulation factor IX
Therapy Area/IndicationsHemophilia B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAbzena Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAbzena LtdCantab BiopharmaceuticalsAscension Healthcare Development Ltd
Active IndicationsN/A
Inactive IndicationsHemophilia B

Other Information

ATC CodeN/A
Related LinksN/A